Published in Nucleic Acids Res on June 15, 1998
Hydroxyurea-stalled replication forks become progressively inactivated and require two different RAD51-mediated pathways for restart and repair. Mol Cell (2010) 4.57
Characterization of homologous recombination induced by replication inhibition in mammalian cells. EMBO J (2001) 2.98
Manipulating the mammalian genome by homologous recombination. Proc Natl Acad Sci U S A (2001) 2.71
Mechanism of radiosensitization by the Chk1/2 inhibitor AZD7762 involves abrogation of the G2 checkpoint and inhibition of homologous recombinational DNA repair. Cancer Res (2010) 2.34
DNA replication is required To elicit cellular responses to psoralen-induced DNA interstrand cross-links. Mol Cell Biol (2000) 2.33
The consequences of Rad51 overexpression for normal and tumor cells. DNA Repair (Amst) (2008) 2.30
Conservative homologous recombination preferentially repairs DNA double-strand breaks in the S phase of the cell cycle in human cells. Nucleic Acids Res (2004) 2.02
Deficiency of human BRCA2 leads to impaired homologous recombination but maintains normal nonhomologous end joining. Proc Natl Acad Sci U S A (2001) 1.97
Fusion tyrosine kinases induce drug resistance by stimulation of homology-dependent recombination repair, prolongation of G(2)/M phase, and protection from apoptosis. Mol Cell Biol (2002) 1.60
RASSF1A-LATS1 signalling stabilizes replication forks by restricting CDK2-mediated phosphorylation of BRCA2. Nat Cell Biol (2014) 1.53
Characterization of mammalian RAD51 double strand break repair using non-lethal dominant-negative forms. EMBO J (2000) 1.49
The Polycomb group protein EZH2 impairs DNA repair in breast epithelial cells. Neoplasia (2005) 1.42
Enhanced cellular radiosensitivity induced by cofilin-1 over-expression is associated with reduced DNA repair capacity. Int J Radiat Biol (2013) 1.42
High-level expression of Rad51 is an independent prognostic marker of survival in non-small-cell lung cancer patients. Br J Cancer (2005) 1.42
RI-1: a chemical inhibitor of RAD51 that disrupts homologous recombination in human cells. Nucleic Acids Res (2012) 1.36
p53 modulates homologous recombination by transcriptional regulation of the RAD51 gene. EMBO Rep (2006) 1.34
Sequestration of mammalian Rad51-recombination protein into micronuclei. J Cell Biol (1999) 1.33
Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation. Cell Death Dis (2012) 1.32
DNA double-strand break repair as determinant of cellular radiosensitivity to killing and target in radiation therapy. Front Oncol (2013) 1.30
Overexpression of human RAD51 and RAD52 reduces double-strand break-induced homologous recombination in mammalian cells. Nucleic Acids Res (2001) 1.26
DNA repair by homologous recombination, but not by nonhomologous end joining, is elevated in breast cancer cells. Neoplasia (2009) 1.24
Ribozyme minigene-mediated RAD51 down-regulation increases radiosensitivity of human prostate cancer cells. Nucleic Acids Res (2001) 1.24
Overexpression of RAD51 suppresses recombination defects: a possible mechanism to reverse genomic instability. Nucleic Acids Res (2009) 1.23
RecA stimulates sister chromatid exchange and the fidelity of double-strand break repair, but not gene targeting, in plants transformed by Agrobacterium. Proc Natl Acad Sci U S A (2000) 1.14
NVP-BEZ235 and NVP-BGT226, dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitors, enhance tumor and endothelial cell radiosensitivity. Radiat Oncol (2012) 1.11
Regulation of double-strand break-induced mammalian homologous recombination by UBL1, a RAD51-interacting protein. Nucleic Acids Res (2000) 1.06
Essential roles of Jab1 in cell survival, spontaneous DNA damage and DNA repair. Oncogene (2010) 0.99
DNA repair after irradiation in glioma cells and normal human astrocytes. Neuro Oncol (2007) 0.99
RAD51 is required for propagation of the germinal nucleus in Tetrahymena thermophila. Genetics (2000) 0.99
Phosphorylation-dependent interactions of BLM and 53BP1 are required for their anti-recombinogenic roles during homologous recombination. Carcinogenesis (2007) 0.98
Targeting of Rad51-dependent homologous recombination: implications for the radiation sensitivity of human lung cancer cell lines. Br J Cancer (2005) 0.98
An optimized RAD51 inhibitor that disrupts homologous recombination without requiring Michael acceptor reactivity. J Med Chem (2012) 0.98
Suppression of Jab1/CSN5 induces radio- and chemo-sensitivity in nasopharyngeal carcinoma through changes to the DNA damage and repair pathways. Oncogene (2012) 0.96
A novel small molecule RAD51 inactivator overcomes imatinib-resistance in chronic myeloid leukaemia. EMBO Mol Med (2013) 0.95
Spontaneous and double-strand break-induced recombination, and gene conversion tract lengths, are differentially affected by overexpression of wild-type or ATPase-defective yeast Rad54. Nucleic Acids Res (2002) 0.94
RAD51 supports spontaneous non-homologous recombination in mammalian cells, but not the corresponding process induced by topoisomerase inhibitors. Nucleic Acids Res (2001) 0.92
A synthetic lethal screen identifies the Vitamin D receptor as a novel gemcitabine sensitizer in pancreatic cancer cells. Cell Cycle (2014) 0.92
Homologous Recombination and Its Role in Carcinogenesis. J Biomed Biotechnol (2002) 0.91
RAD51 Gene 135G/C polymorphism and the risk of four types of common cancers: a meta-analysis. Diagn Pathol (2014) 0.91
Meiosis and the evolution of recombination at low mutation rates. Genetics (2000) 0.89
Design of potent inhibitors of human RAD51 recombinase based on BRC motifs of BRCA2 protein: modeling and experimental validation of a chimera peptide. J Med Chem (2010) 0.89
DNA Damage Signalling and Repair Inhibitors: The Long-Sought-After Achilles' Heel of Cancer. Biomolecules (2015) 0.88
Cell death triggered by alpha-emitting 213Bi-immunoconjugates in HSC45-M2 gastric cancer cells is different from apoptotic cell death. Eur J Nucl Med Mol Imaging (2004) 0.88
Overexpression of Drosophila Rad51 protein (DmRad51) disrupts cell cycle progression and leads to apoptosis. Chromosoma (2004) 0.87
Targeting tumor suppressor networks for cancer therapeutics. Curr Drug Targets (2014) 0.87
A Small-Molecule Inhibitor of RAD51 Reduces Homologous Recombination and Sensitizes Multiple Myeloma Cells to Doxorubicin. Front Oncol (2014) 0.86
Crosstalk between translesion synthesis, Fanconi anemia network, and homologous recombination repair pathways in interstrand DNA crosslink repair and development of chemoresistance. Mutat Res Rev Mutat Res (2014) 0.86
Rad51 expression is a useful predictive factor for the efficacy of neoadjuvant chemoradiotherapy in squamous cell carcinoma of the esophagus. Ann Surg Oncol (2013) 0.86
Is homologous recombination really an error-free process? Front Genet (2014) 0.85
Differential cellular responses to prolonged LDR-IR in MLH1-proficient and MLH1-deficient colorectal cancer HCT116 cells. Clin Cancer Res (2009) 0.85
Association between the RAD51 135 G>C polymorphism and risk of cancer: a meta-analysis of 19,068 cases and 22,630 controls. PLoS One (2013) 0.84
Increased miRNA-22 expression sensitizes esophageal squamous cell carcinoma to irradiation. J Radiat Res (2012) 0.84
Human Rad51 promotes mitochondrial DNA synthesis under conditions of increased replication stress. Mitochondrion (2013) 0.83
Metformin Radiosensitizes p53-Deficient Colorectal Cancer Cells through Induction of G2/M Arrest and Inhibition of DNA Repair Proteins. PLoS One (2015) 0.83
Ca2+ improves organization of single-stranded DNA bases in human Rad51 filament, explaining stimulatory effect on gene recombination. Nucleic Acids Res (2012) 0.83
Enhancement of gene targeting in human cells by intranuclear permeation of the Saccharomyces cerevisiae Rad52 protein. Nucleic Acids Res (2010) 0.82
Transient elevation of glycolysis confers radio-resistance by facilitating DNA repair in cells. BMC Cancer (2015) 0.82
Normal expression of DNA repair proteins, hMre11, Rad50 and Rad51 but protracted formation of Rad50 containing foci in X-irradiated skin fibroblasts from radiosensitive cancer patients. Br J Cancer (2004) 0.81
DNA damage accumulation and repair defects in acute myeloid leukemia: implications for pathogenesis, disease progression, and chemotherapy resistance. Chromosoma (2014) 0.81
In Vivo Delivery of miR-34a Sensitizes Lung Tumors to Radiation Through RAD51 Regulation. Mol Ther Nucleic Acids (2015) 0.80
Comparison of proliferation and genomic instability responses to WRN silencing in hematopoietic HL60 and TK6 cells. PLoS One (2011) 0.80
Rad51 in regulating the radiosensitivity of non-small cell lung cancer with different epidermal growth factor receptor mutation status. Thorac Cancer (2015) 0.78
Methotrexate-mediated inhibition of RAD51 expression and homologous recombination in cancer cells. J Cancer Res Clin Oncol (2012) 0.78
High levels of RAD51 perturb DNA replication elongation and cause unscheduled origin firing due to impaired CHK1 activation. Cell Cycle (2015) 0.78
The Tumor-Associated Variant RAD51 G151D Induces a Hyper-Recombination Phenotype. PLoS Genet (2016) 0.77
The RAD51-stimulatory compound RS-1 can exploit the RAD51 overexpression that exists in cancer cells and tumors. Cancer Res (2014) 0.77
High RAD54B expression: an independent predictor of postoperative distant recurrence in colorectal cancer patients. Oncotarget (2015) 0.76
Tissue-specific effects of valproic acid on DNA repair genes and apoptosis in postimplantation mouse embryos. Toxicol Sci (2014) 0.76
MEK inhibitor GSK1120212-mediated radiosensitization of pancreatic cancer cells involves inhibition of DNA double-strand break repair pathways. Cell Cycle (2015) 0.76
RAD51B Activity and Cell Cycle Regulation in Response to DNA Damage in Breast Cancer Cell Lines. Breast Cancer (Auckl) (2014) 0.76
Current status of and perspectives regarding neoadjuvant chemoradiotherapy for locally advanced esophageal squamous cell carcinoma. Surg Today (2015) 0.75
A peptide nucleic acid targeting nuclear RAD51 sensitizes multiple myeloma cells to melphalan treatment. Cancer Biol Ther (2015) 0.75
Efficiency of olaparib in colorectal cancer patients with an alteration of the homologous repair protein. World J Gastroenterol (2016) 0.75
Targeting Cell Cycle Proteins in Breast Cancer Cells with siRNA by Using Lipid-Substituted Polyethylenimines. Front Bioeng Biotechnol (2015) 0.75
Fibroblast growth factor receptor 4 induced resistance to radiation therapy in colorectal cancer. Oncotarget (2016) 0.75
Overexpression of Rad51 Predicts Poor Prognosis in Colorectal Cancer: Our Experience with 54 Patients. PLoS One (2017) 0.75
Association between a functional variant in RAD51 gene's 3' untranslated region and its mRNA expression in lymphoblastoid cell lines. Springerplus (2016) 0.75
Analogs of the novel phytohormone, strigolactone, trigger apoptosis and synergize with PARP inhibitors by inducing DNA damage and inhibiting DNA repair. Oncotarget (2016) 0.75
Gefitinib Synergizes with Irinotecan to Suppress Hepatocellular Carcinoma via Antagonizing Rad51-Mediated DNA-Repair. PLoS One (2016) 0.75
Enhancement of extra chromosomal recombination in somatic cells by affecting the ratio of homologous recombination (HR) to non-homologous end joining (NHEJ). Anim Biotechnol (2008) 0.75
Gene Targeting Without DSB Induction Is Inefficient in Barley. Front Plant Sci (2017) 0.75
Treatment Outcome and Prognostic Molecular Markers of Supratentorial Primitive Neuroectodermal Tumors. PLoS One (2016) 0.75
The purine scaffold Hsp90 inhibitor PU-H71 sensitizes cancer cells to heavy ion radiation by inhibiting DNA repair by homologous recombination and non-homologous end joining. Radiother Oncol (2016) 0.75
Swi5-Sfr1 protein stimulates Rad51-mediated DNA strand exchange reaction through organization of DNA bases in the presynaptic filament. Nucleic Acids Res (2013) 0.75
Rad51 Expression in Nasopharyngeal Carcinoma and Its Association with Tumor Reduction: A Preliminary Study in Indonesia. Iran J Pathol (2016) 0.75
Overexpression of SKP2 Inhibits the Radiation-Induced Bystander Effects of Esophageal Carcinoma. Int J Environ Res Public Health (2017) 0.75
The RAD51 135G>C polymorphism is related to the effect of adjuvant therapy in early breast cancer. J Cancer Res Clin Oncol (2014) 0.75
Rad51 protein involved in repair and recombination in S. cerevisiae is a RecA-like protein. Cell (1992) 10.78
New procedure for DNA transfection with polycation and dimethyl sulfoxide. Mol Cell Biol (1984) 8.63
Rad51-deficient vertebrate cells accumulate chromosomal breaks prior to cell death. EMBO J (1998) 6.65
A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry (1983) 6.38
Targeted disruption of the Rad51 gene leads to lethality in embryonic mice. Proc Natl Acad Sci U S A (1996) 6.04
A mutation in mouse rad51 results in an early embryonic lethal that is suppressed by a mutation in p53. Mol Cell Biol (1996) 5.75
Human Rad51 protein promotes ATP-dependent homologous pairing and strand transfer reactions in vitro. Cell (1996) 5.29
Sister chromatids are preferred over homologs as substrates for recombinational repair in Saccharomyces cerevisiae. Genetics (1992) 5.02
DNA strand exchange mediated by a RAD51-ssDNA nucleoprotein filament with polarity opposite to that of RecA. Cell (1995) 4.98
Similarity of the yeast RAD51 filament to the bacterial RecA filament. Science (1993) 4.96
Cloning of human, mouse and fission yeast recombination genes homologous to RAD51 and recA. Nat Genet (1993) 4.96
Rad52 protein stimulates DNA strand exchange by Rad51 and replication protein A. Nature (1998) 4.93
Nuclear foci of mammalian Rad51 recombination protein in somatic cells after DNA damage and its localization in synaptonemal complexes. Proc Natl Acad Sci U S A (1995) 4.60
Yeast Rad55 and Rad57 proteins form a heterodimer that functions with replication protein A to promote DNA strand exchange by Rad51 recombinase. Genes Dev (1997) 4.57
Purification and characterization of the human Rad51 protein, an analogue of E. coli RecA. EMBO J (1994) 4.55
Stimulation by Rad52 of yeast Rad51-mediated recombination. Nature (1998) 4.31
Semidominant suppressors of Srs2 helicase mutations of Saccharomyces cerevisiae map in the RAD51 gene, whose sequence predicts a protein with similarities to procaryotic RecA proteins. Mol Cell Biol (1992) 4.04
Nucleotide sequence and transcriptional regulation of the yeast recombinational repair gene RAD51. Mol Cell Biol (1992) 3.74
Synergistic actions of Rad51 and Rad52 in recombination and DNA repair. Nature (1998) 3.57
A single-stranded DNA-binding protein is needed for efficient presynaptic complex formation by the Saccharomyces cerevisiae Rad51 protein. J Biol Chem (1997) 2.95
Activities of human recombination protein Rad51. Proc Natl Acad Sci U S A (1997) 2.39
A table for the estimation of the spontaneous mutation rate of cells in culture. Mutat Res (1973) 2.13
A chicken RAD51 homologue is expressed at high levels in lymphoid and reproductive organs. Nucleic Acids Res (1993) 1.89
Cell cycle responses of two X-ray sensitive mutants defective in DNA repair. Int J Radiat Biol (1989) 1.87
High spontaneous intrachromosomal recombination rates in ataxia-telangiectasia. Science (1993) 1.86
Distribution of the Rad51 recombinase in human and mouse spermatocytes. EMBO J (1997) 1.82
Cloning and sequence of the human RecA-like gene cDNA. Nucleic Acids Res (1993) 1.81
The human Rad51 protein: polarity of strand transfer and stimulation by hRP-A. EMBO J (1997) 1.80
Evidence for DNA-PK-dependent and -independent DNA double-strand break repair pathways in mammalian cells as a function of the cell cycle. Mol Cell Biol (1997) 1.79
Evolutionary comparisons of RecA-like proteins across all major kingdoms of living organisms. J Mol Evol (1997) 1.67
Elevated recombination in immortal human cells is mediated by HsRAD51 recombinase. Mol Cell Biol (1997) 1.54
DNA-PK: at the cross-roads of biochemistry and genetics. Mutat Res (1997) 1.40
Evidence that mammalian cells possess homologous recombinational repair pathways. Mutat Res (1996) 1.32
Double-strand break-induced recombination in eukaryotes. Prog Nucleic Acid Res Mol Biol (1998) 1.28
Expression of human RAD52 confers resistance to ionizing radiation in mammalian cells. J Biol Chem (1995) 1.22
Increase of spontaneous intrachromosomal homologous recombination in mammalian cells expressing a mutant p53 protein. Oncogene (1997) 1.19
Characterization of strand exchange activity of yeast Rad51 protein. Mol Cell Biol (1997) 1.16
The influence of adenine-rich motifs in the 3' portion of the ribosome binding site on human IFN-gamma gene expression in Escherichia coli. J Mol Biol (1994) 1.11
Carcinogens stimulate intrachromosomal homologous recombination at an endogenous locus in human diploid fibroblasts. Mutat Res (1997) 1.11
Novel lacZ-based recombination vectors for mammalian cells. Gene (1993) 1.01
Studies on intrachromosomal recombination in SP5/V79 Chinese hamster cells upon exposure to different agents related to carcinogenesis. Carcinogenesis (1994) 0.89
Mutagen-induced recombination in mammalian cells in vitro. Mutat Res (1992) 0.85
Induced recombination between duplicated neo genes stably integrated in the genome of CHO cells. Mutat Res (1989) 0.83
Ultraviolet reactivation and ultraviolet mutagenesis of lambda in different genetic systems. Virology (1971) 2.83
Induction kinetics of mutagenic DNA repair activity in E. coli following ultraviolet irradiation. Mol Gen Genet (1976) 1.88
Molecular mechanisms of induced mutagenesis. Replication in vivo of bacteriophage phiX174 single-stranded, ultraviolet light-irradiated DNA in intact and irradiated host cells. J Mol Biol (1977) 1.78
Pathways of mutagenesis and repair in Escherichia coli exposed to low levels of simple alkylating agents. J Bacteriol (1978) 1.43
A 'DNA replication' signature of progression and negative outcome in colorectal cancer. Oncogene (2009) 1.33
The p400/Tip60 ratio is critical for colorectal cancer cell proliferation through DNA damage response pathways. Oncogene (2009) 1.30
Role of the E. coli umuC gene product in the repair of single-stranded DNA phage. Mol Gen Genet (1983) 1.25
Overexpression of DNA polymerase beta in cell results in a mutator phenotype and a decreased sensitivity to anticancer drugs. Proc Natl Acad Sci U S A (1998) 1.24
Signal of induction of recA protein in E. coli. Mutat Res (1984) 1.20
The adaptive response of E.coli to low levels of alkylating agent: the role of polA in killing adaptation. Mol Gen Genet (1978) 1.17
Concomitant expression of E. coli cytosine deaminase and uracil phosphoribosyltransferase improves the cytotoxicity of 5-fluorocytosine. FEMS Microbiol Lett (1998) 1.15
Enhanced expression and activity of DNA polymerase beta in human ovarian tumor cells: impact on sensitivity towards antitumor agents. Oncogene (2001) 1.15
The role of umuC gene product in mutagenesis by simple alkylating agents. Mol Gen Genet (1980) 1.13
In vivo gene silencing in solid tumors by targeted electrically mediated siRNA delivery. Gene Ther (2007) 1.06
DNA replication stress response involving PLK1, CDC6, POLQ, RAD51 and CLASPIN upregulation prognoses the outcome of early/mid-stage non-small cell lung cancer patients. Oncogenesis (2012) 1.00
Fork-like DNA templates support bypass replication of lesions that block DNA synthesis on single-stranded templates. Proc Natl Acad Sci U S A (1996) 0.98
Cetuximab potentiates oxaliplatin cytotoxic effect through a defect in NER and DNA replication initiation. Br J Cancer (2008) 0.97
Adaptation to DNA damage and stimulation of genetic instability: the double-edged sword mammalian DNA polymerase kappa. Biochimie (2005) 0.96
Overexpression of DNA polymerase beta: a genomic instability enhancer process. FASEB J (1999) 0.96
Recovery of respiration following the SOS response of Escherichia coli requires RecA-mediated induction of 2-keto-4-hydroxyglutarate aldolase. Proc Natl Acad Sci U S A (1995) 0.95
Characterization of promoter regulatory elements involved in downexpression of the DNA polymerase kappa in colorectal cancer. Oncogene (2006) 0.95
Mutagenesis in monkey cells of a vector containing a single d(GPG) cis-diamminedichloroplatinum(II) adduct placed on codon 13 of the human H-ras proto-oncogene. Nucleic Acids Res (1994) 0.95
Mutator phenotype of BCR--ABL transfected Ba/F3 cell lines and its association with enhanced expression of DNA polymerase beta. Oncogene (1999) 0.93
New mutations in and around the L2 disordered loop of the RecA protein modulate recombination and/or coprotease activity. J Bacteriol (1992) 0.93
Nucleotide excision repair DNA synthesis by excess DNA polymerase beta: a potential source of genetic instability in cancer cells. FASEB J (2000) 0.93
Novel evidences for a tumor suppressor role of Rev3, the catalytic subunit of Pol zeta. Oncogene (2008) 0.92
RAD51 supports spontaneous non-homologous recombination in mammalian cells, but not the corresponding process induced by topoisomerase inhibitors. Nucleic Acids Res (2001) 0.92
Ellipticine and derivatives induce breakage of L1210 cells DNA in vitro. Biochem Pharmacol (1979) 0.91
Effect of the adaptive response on the induction of the SOS pathway in E. coli K-12. Mol Gen Genet (1980) 0.91
Modulation of cellular response to cisplatin by a novel inhibitor of DNA polymerase beta. Mol Pharmacol (2005) 0.91
Characterization of dinY, a new Escherichia coli DNA repair gene whose products are damage inducible even in a lexA(Def) background. J Bacteriol (1993) 0.90
Activated RecA protein may induce expression of a gene that is not controlled by the LexA repressor and whose function is required for mutagenesis and repair of UV-irradiated bacteriophage lambda. J Bacteriol (1987) 0.89
Antitumor activity of 2',3'-dideoxycytidine nucleotide analog against tumors up-regulating DNA polymerase beta. Mol Pharmacol (2001) 0.89
The equine herpes virus 4 thymidine kinase is a better suicide gene than the human herpes virus 1 thymidine kinase. Gene Ther (1999) 0.88
Phage yield during W-reactivation of bacteriophage. Mutat Res (1977) 0.88
UV induction of LexA independent proteins which could be involved in SOS repair. Biochimie (1991) 0.87
Weigle reactivation and mutagenesis of bacteriophage lambda in lexA(Def) mutants of E. coli K12. Mol Gen Genet (1985) 0.86
Involvement of apoptosis in mitomycin C hypersensitivity of Chinese hamster cell mutants. Biochem Pharmacol (2000) 0.86
Induction of recA protein in Escherichia coli by three platinum (II) compounds. Biochem Biophys Res Commun (1982) 0.86
Effects of a single intrastrand d(GpG) platinum adduct on the strand separating activity of the Escherichia coli proteins RecB and RecA. FEBS Lett (1993) 0.85
DNA polymerase beta imbalance increases apoptosis and mutagenesis induced by oxidative stress. FEBS Lett (2001) 0.84
cis-Pt(NH3)2Cl2 and trans-Pt(NH3)2Cl2 inhibit DNA synthesis in cultured L1210 leukemia cells. Biochem Biophys Res Commun (1983) 0.83
UV reactivation of phage lambda in a polA mutant of E. coli. Mutat Res (1972) 0.83
Mammalian Rad51 protein: a RecA homologue with pleiotropic functions. Biochimie (1997) 0.83
Characterization and localization of cis-diamminedichloro-platinum(II) adducts on a purified oligonucleotide containing the codons 12 and 13 of H-ras proto-oncogene. Nucleic Acids Res (1992) 0.82
A bacterial strain for detecting agents that produce free radical-mediated DNA strand breaks. Mutat Res (1987) 0.81
Inducibility of the SOS response in a recA730 or recA441 strain is restored by transformation with a new recA allele. Mol Gen Genet (1993) 0.81
Kinetics of induction of error-prone repair of bacteriophage lambda by temperature shift in an Escherichia coli dnaB mutant. Mol Gen Genet (1977) 0.81
Overexpression of DNA polymerase beta sensitizes mammalian cells to 2',3'-deoxycytidine and 3'-azido-3'-deoxythymidine. Cancer Res (1997) 0.81
Modulation of the SOS response by truncated RecA proteins. Mol Gen Genet (1989) 0.80
Translesion synthesis is the main component of SOS repair in bacteriophage lambda DNA. J Bacteriol (1989) 0.80
DNA synthesis, mismatch repair and cancer. Int J Oncol (1998) 0.80
Protein A insensitive ELISA detection of staphylococcal enterotoxin B. Lett Appl Microbiol (1991) 0.79
Lack of correlation between repair of DNA interstrand cross-links and hypersensitivity of hamster cells towards mitomycin C and cisplatin. FEBS Lett (1998) 0.79
Site-directed mutagenesis in the Escherichia coli recA gene. Biochimie (1991) 0.78
The adaptive response in E. coli. Biochimie (1985) 0.77
Equilibrium binding of single-stranded DNA to the secondary DNA binding site of the bacterial recombinase RecA. J Biol Chem (2000) 0.77
Nonsteroidal antiinflammatory drug-photosensitized formation of pyrimidine dimer in DNA. Biochem Pharmacol (1998) 0.77
Purification and biochemical characterization of Escherichia coli RecA proteins mutated in the putative DNA binding site. J Biol Chem (1994) 0.77
Repair of platinum-DNA lesions in E. coli by a pathway which does not recognize DNA damage caused by MNNG or UV light. Mutat Res (1985) 0.77
Genetical and biochemical evidence for the involvement of the coprotease domain of Escherichia coli RecA protein in recombination. J Mol Biol (1992) 0.77
Analysis of DNA polymerase activity in vitro using non-radioactive primer extension assay in an automated DNA sequencer. Genet Mol Res (2007) 0.76
Replication of DNA containing cisplatin lesions and its mutagenic consequences. Biochimie (1995) 0.76
Investigation of the secondary DNA-binding site of the bacterial recombinase RecA. J Biol Chem (1998) 0.76
The Mars Sample Return Project. Acta Astronaut (2001) 0.76
3R gene expression in chronic lymphocytic leukemia reveals insight into disease evolution. Blood Cancer J (2016) 0.75
Transcription-coupled repair is inducible in hamster cells. Nucleic Acids Res (2000) 0.75
Replication of chemically modified DNA. Biochimie (1978) 0.75
Enhanced mutagenesis during post-treatment incubation of Escherichia coli treated with cis-diamminedichloroplatinum(II). Mutat Res (1988) 0.75
Characterization of mitochondrial DNA from the pika (Ochotona rufescens rufescens). Z Naturforsch C (1976) 0.75
Increased proliferative activity, loss of beta-adrenergic receptor function and class I major histocompatibility complex antigen surface expression in a modified lymphoma cell line. Cell Signal (1994) 0.75
[Cowpox virus infection in a child]. Arch Pediatr (2004) 0.75
Isolation and characterization of HC1: a novel human DNA repair gene. Genet Mol Res (2009) 0.75
Characterization of the sensitivity to various genotoxic agents of the UVU1-CHO cell line, a double mutant from UV complementation group 1. Biochimie (1997) 0.75
RECA immunological assay as a tool to analyze the SOS response. Biochimie (1985) 0.75
Further characterization of an E. coli strain resistant to the toxic and mutagenic action of cis-diamminedichloroplatinum(II). Mutat Res (1987) 0.75
[Genetic recombination and "lex" function in UV reactivation and mutagenesis of phage lambda]. Arch Int Physiol Biochim (1970) 0.75
[The child with neurologic or neuromuscular handicaps]. Soins Pediatr Pueric (1998) 0.75